Quantification of DNA adducts in individual cells by immunofluorescence: Effects of variation in DNA conformation

Experimental Cell Research

Volumn 283, Issue 2, 2003, Pages 127-134

  Frank, Adrian J ^a,b   Tilby, Michael J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

COMET; DNA adducts; DNA strand breaks; Immunofluorescence; Melphalan; TARDIS

Indexed keywords

AGAROSE; ALKALI; CELL DNA; DYE; FLUORESCEIN; MELPHALAN;

ARTICLE; CELL HETEROGENEITY; CONTROLLED STUDY; CYTOLYSIS; DNA ADDUCT; DNA CONFORMATION; DNA CONTENT; DNA DENATURATION; DNA STRAND BREAKAGE; FLUORESCENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; LEUKEMIA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION EXPOSURE; SAMPLE; STAINING; TIME;

EID: 0037442852     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00026-5     Document Type: Article

References (34)

1. Hong M.Y., Chapkin R.S., Morris J.S., Wang N., Carroll R.J., Turner N.D., Chang W.C., Davidson L.A., Lupton J.R. Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model. Carcinogenesis. 22:2001;1831-1835.
2. Kobayashi N., Katsumi S., Imoto K., Nakagawa A., Miyagawa S., Furumura M., Mori T. Quantitation and visualization of ultraviolet-induced DNA damage using specific antibodies Application to pigment cell biology . Pigment Cell Res. 14:2001;94-102.
3. Li D., Zhang W., Zhu J., Chang P., Sahin A., Singletary E., Bondy M., Hazra T., Mitra S., Lau S.S., Shen J., DiGiovanni J. Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol. Carcinog. 31:2001;214-223.
4. Otani K., Shimizu S., Chijiiwa K., Yamaguchi K., Noshiro H., Tanaka M. Immunohistochemical detection of 8-hydroxy-2′-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction. Eur. J. Gastroenterol. Hepatol. 13:2001;1363-1369.
5. van de Vaart P.J., Belderbos J., de Jong D., Sneeuw K.C., Majoor D., Bartelink H., Begg A.C. DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy. Int. J. Cancer. 89:2000;160-166.
6. Cooke M.S., Mistry N., Ladapo A., Herbert K.E., Lunec J. Immunochemical quantitation of UV-induced oxidative and dimeric DNA damage to human keratinocytes. Free Radic. Res. 33:2000;369-381.
7. Ide F., Iida N., Nakatsuru Y., Oda H., Nikaido O., Ishikawa T. In vivo detection of ultraviolet photoproducts and their repair in purkinje cells. Lab. Invest. 80:2000;465-470.
8. Katiyar S.K., Matsui M.S., Mukhtar H. Kinetics of UV light-induced cyclobutane pyrimidine dimers in human skin in vivo An immunohistochemical analysis of both epidermis and dermis . Photochem. Photobiol. 72:2000;788-793.
9. Rundle A., Tang D., Zhou J., Cho S., Perera F. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol. Biomarkers. Prev. 9:2000;1079-1085.
10. Kaufmann H., Urbauer E., Ackermann J., Huber H., Drach J. Advances in the biology and therapeutic management of multiple myeloma. Ann. Hematol. 80:2001;445-451.
11. Kyle R.A. Update on the treatment of multiple myeloma. Oncologist. 6:2001;119-124.
12. Zervas K., Pouli A., Gregoraki B., Anagnostopoulos N., Dimopoulos M.A., Bourantas K., Tzilianos M., Barbarousi D., Venetis E., Vyniou N., Maniatis A. Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma A prospective randomized study . Eur. J. Haematol. 66:2001;18-23.
13. Desikan R., Barlogie B., Sawyer J., Ayers D., Tricot G., Badros A., Zangari M., Munshi N.C., Anaissie E., Spoon D., Siegel D., Jagannath S., Vesole D., Epstein J., Shaughnessy J., Fassas A., Lim S., Roberson P., Crowley J. Results of high-dose therapy for 1000 patients with multiple myeloma Durable complete remissions and superior survival in the absence of chromosome 13 abnormalities . Blood. 95:2000;4008-4010.
14. Kulkarni S., Powles R., Treleaven J., Singhal S., Horton C., Sirohi B., Bhagawati N., Tait D., Saso R., Killick S., Pinkerton R., Atra A., Meller S., Mehta J. Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning Follow-up of 725 patients from a single centre over a period of 26 years . Bone Marrow Transplant. 25:2000;365-370.
15. Tilby M.J., Lawley P.D., Farmer P.B. Alkylation of DNA by melphalan in relation to immunoassay of melphalan-DNA adducts Characterization of mono-alkylated and cross-linked products from reaction of melphalan with dGMP and GMP . Chem. Biol. Interactions. 73:1990;183-194.
16. Osborne M.R., Lawley P.D. Alkylation of DNA by melphalan with special reference to adenine derivatives and adenine-guanine cross-linking. Chem. Biol. Interactions. 89:1993;49-60.
17. Osborne M.R., Lawley P.D. The reaction of melphalan with deoxyguanosine and deoxyguanylic acid. Chem. Biol. Interactions. 84:1992;189-198.
18. Osborne M.R., Lawley P.D., Crofton-Sleigh C., Warren W. Products from alkylation of DNA in cells by melphalan Human soft tissue sarcoma cell line RD and Escherichia coli WP2 . Chem. Biol. Interactions. 97:1995;287-296.
19. Tilby M.J., McCartney H., Gould K.A., O'Hare C.C., Hartley J.A., Hall A.G., Golding B.T., Lawley P.D. A monofunctional derivative of melphalan Preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts . Chem. Res. Toxicol. 11:1998;1162-1168.
20. Tilby M.J., Newell D.R., Viner C., Selby P.J., Dean C.J. Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy. Eur. J. Cancer. 29A:1993;681-686.
21. Tilby M.J., Styles J.M., Dean C.J. Immunological detection of DNA damage caused by melphalan using monoclonal antibodies. Cancer Res. 47:1987;1542-1546.
22. Frank A.J., Proctor S.J., Tilby M.J. Detection and quantification of melphalan-DNA adducts at the single cell level in hemopoietic tumor cells. Blood. 88:1996;977-984.
23. Frank A.J. Measuring DNA adducts in single cells. Brown R., Böger-Brown U. Cytotoxic Drug Resistance Mechanisms. 1999;Humana Press, Totowa, NJ.
24. Padget K., Carr R., Pearson A.D.J., Tilby M.J., Austin C.A. Camptothecin stabilised topoisomerase I-DNA complexes in leukaemia cells visualised and quantified in situ by the TARDIS assay (trapped in agarose DNA immunostaining). Biochem. Pharmacol. 59:1999;629-638.
25. Willmore E., Frank A.J., Padget K., Tilby M.J., Austin C.A. Etoposide targets topoisomerase IIα and IIβ in leukemic cells Isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique . Mol. Pharmacol. 53:1998;78-85.
26. Tilby M.J., McCartney H., Cordell J., Frank A.J., Dean C.J. A monoclonal antibody that recognises alkali-stabilised melphalan-DNA adducts and its application in immunofluorescence microscopy. Carcinogenesis. 16:1995;1895-1901.
27. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
28. Ward J.F. DNA damage in mammalian cells. Free Radic. Res. Commun. 6:1989;179-180.
29. Ward J.F. DNA damage produced by ionizing radiation in mammalian cells Identities, mechanisms of formation, and reparability . Prog. Nucleic Acid. Res. Mol. Biol. 35:1988;95-125.
30. Hartley J.M., Spanswick V.J., Gander M., Giacomini G., Whelan J., Souhami R.L., Hartley J.A. Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. Clin. Cancer Res. 5:1999;507-512.
31. McCartney H., Martin A.M., Middleton P.G., Tilby M.J. Antibody recognition of melphalan adducts characterised using immobilized DNA Enhanced alkylation of G-rich regions in cells compared to in vitro . Chem. Res. Toxicol. 14:2001;71-81.
32. Ahnström G., Erixon K. Radiation induced strand breakage in DNA from mammalian cells. Strand separation in alkaline solution. Int. J. Radiat. Biol. 23:1973;285-289.
33. Ahnström G., Edvardsson K.A. Radiation induced single-strand breaks in DNA determined by rate of alkaline strand separation and hydroxyapatite chromatography An alternative to velocity sedimentation . Int. J. Radiat. Biol. 26:1974;493-497.
34. Gould K.A., McCartney H., Lawley P.D., Golding B.T., Tilby M.J. Specificity of p53 elevation and its role in drug action p53 induction by measured levels of specific DNA adducts . Proc. Am. Assoc. Cancer Res. 38:1997;2. (Abstract).